États-Unis · Bourse & Finance · The Motley Fool

Eli Lilly's weight loss drug business

Publié par The Motley Fool · États-Unis il y a 10 h

And this spring, Lilly won regulatory approval for Foundayo. All three are part of a class of drugs known as GLP-1. These products interact with hormonal pathways involved in…

Lire l'article complet sur The Motley Fool Connectez-vous pour sauvegarder

MediaNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (www.fool.com)

Eli Lilly's weight loss drug business

À lire aussi

My 16-year-old still has a 9 p.m. bedtime. It's great for our whole family.

Artificial Intelligence Stocks Under $10

‘A Republic, if you can keep it’: We served presidents from both parties and have never been so concerned about election security

Berkshire buys more Lennar shares, but pace of purchases slows

Good schools come with a hefty homebuyer's premium in these 10 U.S. cities

Former Dodgers Recruit, Black Yankees Backstop And Florida Baseball Legend Dies At 88

Eli Lilly's weight loss drug business

Partager

À lire aussi

My 16-year-old still has a 9 p.m. bedtime. It's great for our whole family.

Artificial Intelligence Stocks Under $10

‘A Republic, if you can keep it’: We served presidents from both parties and have never been so concerned about election security

Berkshire buys more Lennar shares, but pace of purchases slows

Good schools come with a hefty homebuyer's premium in these 10 U.S. cities

Former Dodgers Recruit, Black Yankees Backstop And Florida Baseball Legend Dies At 88